Insmed Shares Rise Following Reports of Potential Acquisition Interest from Sanofi

Shares of Insmed (INSM) surged 6.9% following reports that pharmaceutical giant Sanofi (SNY) is evaluating a potential acquisition of the drugmaker. According to reports, Sanofi has engaged advisers to explore the possibility of a deal. The market reacted divergently to the news; while Insmed's stock price climbed on takeover speculation, Sanofi ADRs saw a decline of 3%. The move highlights ongoing consolidation trends within the biotechnology and pharmaceutical sectors as larger firms seek to bolster their drug pipelines.

By https://seekingalpha.com/author/sa-editor-joshua-fineman · Seeking Alpha ·

Insmed Shares Rise Following Reports of Potential Acquisition Interest from Sanofi

Tickers: $INSM $SNY

Topics: Biotechnology M&A Pharmaceuticals

Read the full article at Seeking Alpha

Part of the story Rhythm Pharmaceuticals Shares Rise Following Reports of Potential Eli Lilly Acquisition Interest (3 articles)

More World news